News

BioPharma Dive16h
Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division
In its first full year on the U.S. market, bladder cancer treatment Adstiladrin earned about $77 million. Elsewhere, Lilly ...
Barchart on MSN17h
Stocks Search for Direction as China, Europe Retaliate on Tariffs
The S&P 500 Index ($SPX) (SPY) today is up +0.60%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.40%, and the Nasdaq ...
FDA Approves Bristol Myers' Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients
The FDA has approved Opdivo plus Yervoy for the first-line treatment of MSI-H/dMMR colorectal cancer, supported by the Phase ...
Barchart on MSN18h
Stocks Supported by Strength in Megacap Technology and Airline Stocks
The S&P 500 Index ($SPX) (SPY) today is up +0.64%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.29%, and the Nasdaq ...
pharmaphorum20h
BMS bags a double-quick colorectal cancer approval from FDA
The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of ...